19 Dec 2025
DLA Piper Advises Endorfina Shareholders on Sale of 51% Stake to Benefit Systems
"DLA Piper advised the shareholders of Endorfina Group and Endorfina FHU on the sale of a 51% stake to Benefit Systems, with PwC Legal advising Benefit Systems. The majority stake is projected at PLN 95.4m; the final price will be adjusted based on 2025 normalized EBITDA using a single-digit multiple. Benefit Systems will buy the remaining 49% in 2027."